Business, Government and Non-profit News

Stories that the Mainstream Media is missing. Carefully created to keep you in the know.

Sales Nexus CRM
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma Ltd. is progressing its novel multiple sclerosis therapy Lucid-MS to Phase 2 trials, offering a potential non-immunomodulatory appro...

June 22, 2026Read the full article →
Greenland Mines Awards Drilling Contract for 2026 Skaergaard Field Program

Greenland Mines Awards Drilling Contract for 2026 Skaergaard Field Program

Greenland Mines Ltd has signed a diamond drilling contract with Nordisk Fundering A/S for its 2026 field campaign at the Skaergaard project, advancing...

June 22, 2026Read the full article →
AI Integration in Ecommerce Undermines Consumer Trust, Study Reveals

AI Integration in Ecommerce Undermines Consumer Trust, Study Reveals

A new study finds that while AI enhances ecommerce convenience, it also erodes shopper trust, posing challenges for platforms like Alibaba.

June 22, 2026Read the full article →
MiCA Deadline Looms as Most EU Crypto Firms Remain Unauthorized

MiCA Deadline Looms as Most EU Crypto Firms Remain Unauthorized

With the MiCA transition period ending July 1, most European crypto firms have not yet obtained authorization, potentially disrupting operations for m...

June 22, 2026Read the full article →
Nocera Highlights CampaignPulse.ai Investment and Expands AI Platform Vision

Nocera Highlights CampaignPulse.ai Investment and Expands AI Platform Vision

Nocera, Inc. provided details on its minority equity investment in CampaignPulse.ai, an AI-driven platform for simulating audience responses and testi...

June 22, 2026Read the full article →
Global Clean Energy Investment Surpasses Fossil Fuels, IEA Reports

Global Clean Energy Investment Surpasses Fossil Fuels, IEA Reports

The International Energy Agency's latest report reveals that global investment in clean energy has reached record levels, surpassing fossil fuel inves...

June 22, 2026Read the full article →
Quantum BioPharma’s Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Advancing to Phase 2 Trials

Quantum BioPharma’s Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Advancing to Phase 2 Trials

Quantum BioPharma’s patented drug candidate Lucid-MS, which directly targets myelin repair, is set to enter phase 2 clinical trials, offering a potent...

June 22, 2026Read the full article →
DNA Damage Response Inhibitors Poised to Reshape Oncology as Market Approaches $750 Billion by 2030

DNA Damage Response Inhibitors Poised to Reshape Oncology as Market Approaches $750 Billion by 2030

The expansion of DNA Damage Response inhibitors beyond PARP inhibitors, with Onco-Innovations leading a new wave of therapies, signals a transformativ...

June 22, 2026Read the full article →
Fed Holds Rates Steady but Signals Possible Hike Later This Year Amid Inflation Concerns

Fed Holds Rates Steady but Signals Possible Hike Later This Year Amid Inflation Concerns

The Federal Reserve kept lending rates unchanged due to uncertainty from high energy prices linked to the Middle East conflict, but hinted at a potent...

June 22, 2026Read the full article →
Nightfood Holdings Sees Opportunity in AI Infrastructure Automation Boom

Nightfood Holdings Sees Opportunity in AI Infrastructure Automation Boom

As tech giants invest hundreds of billions in AI infrastructure, Nightfood Holdings expands its robotics platform into new industrial sectors through ...

June 22, 2026Read the full article →
Silvercorp Metals Approves $196.3 Million Budget for Kyrgyz Gold Project Development

Silvercorp Metals Approves $196.3 Million Budget for Kyrgyz Gold Project Development

Silvercorp Metals has approved a $196.3 million budget for its joint venture in the Kyrgyz Republic to advance the Tulkubash and Kyzyltash gold projec...

June 22, 2026Read the full article →
Onco-Innovations Targets Next Wave of DNA Damage Response Cancer Therapies Beyond PARP Inhibitors

Onco-Innovations Targets Next Wave of DNA Damage Response Cancer Therapies Beyond PARP Inhibitors

Onco-Innovations is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor, positioning itself as an early leader in a novel class of cancer the...

June 22, 2026Read the full article →